UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000000890
Receipt number R000001068
Scientific Title Japan Elderly Diabetes Intervention Study
Date of disclosure of the study information 2007/11/22
Last modified on 2007/11/14 19:45:47

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Japan Elderly Diabetes Intervention Study

Acronym

J-EDIT

Scientific Title

Japan Elderly Diabetes Intervention Study

Scientific Title:Acronym

J-EDIT

Region

Japan


Condition

Condition

Diabetes Mellitus in the Elderly

Classification by specialty

Endocrinology and Metabolism Geriatrics

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To examine the effects of multifactorial interventions on micro- and macrovacular complications, mortality, and prognosis of physical, cognitive, and psychological functions.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase

Not applicable


Assessment

Primary outcomes

1.Fatal endpoints: diabetes-specific death including cardiovaslular death, and non-diabetes-specific death
2.Non-fatal endpoints: acute myocardial infarction, other IHDs, cerebrovascular disease, arterial peripheral vascular disease, diabetic gangrene, and the blindness due to diabetic retinopathy.

Key secondary outcomes

Diabetic microangiopathy(reitinopathy, nephropathy,neuropathy), vitreous hemorrhage, congestive heart failure, and retinal photocoagulation.


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -no one is blinded

Control

Active

Stratification


Dynamic allocation

YES

Institution consideration

Institution is considered as adjustment factor in dynamic allocation.

Blocking


Concealment

Central registration


Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

Intensive treatment group: HbA1c<6.5%, Blood preesure <130/85mmHg,Total cholesterol:<180mg/dl (If CHD is present), or <200mg/dl (If CHD is absent),Triglycerides<150mg/dl, HDL cholesterol>40mg/dl, and BMI<25.

Interventions/Control_2

Conventional treatment group: goals as attending doctors consider to be proper.
:at least fasting plasma glucose <200mg/dl or HbA1c<9.0%

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

65 years-old <=

Age-upper limit

85 years-old >

Gender

Male and Female

Key inclusion criteria

diabetic patients aged 65-84 years
both sexes
HbA1c 7.0% or greater
If HbA1c is between 7.0 and 7.5 %, the values of blood preesures, serum lipid, or BMI do not reach the goals of the treatment.

Key exclusion criteria

type 1 diabetes
acute disease
malignancy

Target sample size

1500


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Hideki Ito

Organization

Tokyo Metropolitan Geriatric Hospital

Division name

President

Zip code


Address

35-2 Sakae-cho, Itabashi-ku, Tokyo173-0015, Japan

TEL

03-3964-1141

Email



Public contact

Name of contact person

1st name
Middle name
Last name Atsushi Araki

Organization

Tokyo Metropolitan Geriatric Hospital

Division name

Division of Endocrinology

Zip code


Address

35-2 Sakae-cho, Itabashi-ku, Tokyo173-0015, Japan

TEL

03-3964-1141

Homepage URL


Email



Sponsor or person

Institute

Japan Foundation for Health and Aging

Institute

Department

Personal name



Funding Source

Organization

Japan Foundation for Health and Aging

Organization

Division

Category of Funding Organization

Nationality of Funding Organization

Japan


Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2007 Year 11 Month 22 Day


Related information

URL releasing protocol


Publication of results

Partially published


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

No longer recruiting

Date of protocol fixation

2001 Year 02 Month 03 Day

Date of IRB


Anticipated trial start date

2001 Year 03 Month 01 Day

Last follow-up date

2007 Year 09 Month 01 Day

Date of closure to data entry

2008 Year 09 Month 01 Day

Date trial data considered complete

2008 Year 12 Month 01 Day

Date analysis concluded

2009 Year 12 Month 01 Day


Other

Other related information



Management information

Registered date

2007 Year 11 Month 14 Day

Last modified on

2007 Year 11 Month 14 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000001068


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name